FindTrial
Sign In

Biomarker discovery in pancreatobiliary cancer, solid pseudopapillary neoplasm and neuroendocrine tumor, and clinical validation of the candidate biomarkers

Biomarker discovery in pancreatobiliary cancer, solid pseudopapillary neoplasm and neuroendocrine tumor, and clinical validation of the candidate biomarkers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000436
Enrollment
40
Registered
2012-05-07
Start date
2012-02-13
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor
Yonsei Proteome Research Center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient with pancreas neoplasm identified by image analysis and scheduled for curative resection

Exclusion criteria

Exclusion criteria: Pancreatic tumor patients with distant metastasis

Design outcomes

Primary

MeasureTime frame
Proteins and mRNAs overexpressed in the pancreas neoplasm—

Secondary

MeasureTime frame
Survival and recurrence of patients—

Countries

Korea, Republic of

Contacts

Public ContactYoung-Ki Paik

Yonsei Proteome Research Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026